Fed. Circ. To Reconsider Tafas V. Doll

By Erin Coe

Law360, New York (July 07, 2009, 12:00 AM ET) -- A federal appeals court has decided to rethink a March ruling that restored most of the U.S. Patent and Trademark Office’s controversial rules aimed at curtailing prosecution abuses and cutting down the patent application backlog.

The U.S. Court of Appeals for the Federal Circuit on Monday granted a combined petition by pharmaceutical firm GlaxoSmithKline PLC and inventor Triantafyllos Tafas for a rehearing en banc of the case they brought in opposition to the USPTO’s rules.

Finding that a rehearing by its full panel of judges was...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles